PT  - JOURNAL ARTICLE
AU  - Kersemans, Veerle
AU  - Cornelissen, Bart
AU  - Bacher, Klaus
AU  - Kersemans, Ken
AU  - Thierens, Hubert
AU  - Dierckx, Rudi A.
AU  - De Spiegeleer, Bart
AU  - Slegers, Guido
AU  - Mertens, John
TI  - In Vivo Evaluation and Dosimetry of <sup>123</sup>I-2-Iodo-<span class="sc">d</span>-Phenylalanine, a New Potential Tumor-Specific Tracer for SPECT, in an R1M Rhabdomyosarcoma Athymic Mouse Model
DP  - 2005 Dec 01
TA  - Journal of Nuclear Medicine
PG  - 2104--2111
VI  - 46
IP  - 12
4099  - http://jnm.snmjournals.org/content/46/12/2104.short
4100  - http://jnm.snmjournals.org/content/46/12/2104.full
SO  - J Nucl Med2005 Dec 01; 46
AB  - Earlier reports described the preferential uptake of d-amino acids in tumor-bearing mice. Moreover, it was shown that in tumor cells in vitro the l-amino acid transporter system seemed to lack stereospecificity. Because of the successful results with 123/125I-2-iodo-l-phenylalanine, 123/125I-2-iodo-d-phenylalanine was developed, and its tumor-detecting characteristics were evaluated in vivo. Methods: 123I labeling of 2-iodo-d-phenylalanine was performed with a kit formulation by use of Cu1+-assisted nucleophilic exchange. 123I-2-Iodo-d-phenylalanine was evaluated in R1M tumor–bearing athymic mice by dynamic planar imaging (DPI) and dissection. The in vivo stability of the tracer was tested by high-performance liquid chromatography. Tumor tracer retention and tracer contrast were evaluated as a function of time. Two-compartment blood modeling from DPI results and dosimetric calculations from biodistribution results were carried out. Moreover, 125I-2-iodo-d-phenylalanine and 18F-FDG uptake in acute inflammation was investigated. Results: 123I-2-Iodo-d-phenylalanine was metabolically stable. Fast, high, and specific tumor retention was observed. Two-compartment modeling confirmed the fast clearance of the tracer through the kidneys to the bladder, as observed by DPI and dissection. Moreover, compared with the l-isomer, 123I-2-iodo-d-phenylalanine demonstrated faster clearance and faster uptake in the peripheral compartment. No accumulation in the abdomen or in the brain was noted. Dosimetry revealed that 123I-2-iodo-d-phenylalanine demonstrated a low radiation burden comparable to those of 123I-2-iodo-l-phenylalanine and 123I-2-iodo-l-tyrosine. Although 123I-2-iodo-d-phenylalanine showed a tumor retention of only 4%, the tumor contrast was increased up to 350% at 19 h after injection. Conclusion: 123I-2-Iodo-d-phenylalanine is a promising tracer for diagnostic oncologic imaging because of its high, fast, and specific tumor uptake and fast clearance from blood.